Derivatives: Anticipated adjustment due to extraor
Post# of 301275
(Total Views: 66)
Posted On: 04/13/2017 6:00:18 AM
Derivatives: Anticipated adjustment due to extraordinary dividend in Karo Pharma (14/17)
The following information is based on a press release from Karo Pharma AB (Karo Pharma) published April 10, 2017 and may be subject to change.
The board of Karo Pharma has proposed that the Annual General Meeting (AGM) scheduled for May 11, 2017, approves an extraordinary dividend of SEK 0.22 per share in addition to the ordinary dividend of SEK 0.28 per share. The scheduled Ex-date is May 12, 2017. This extraordinary dividend will replace share distribution previously communicated in exchange notice 17/16. Provided that the AGM approves the proposal, NASDAQ Derivatives Markets will carry out a re-calculation of stock options, forwards and futures in Karo Pharma (KAROB).
For further information please find attached file.
(0)
(0)